Valneva SE VALN
5.92 USD +0.05 (+0.85%)
At closeNov 11, 2026, 4:00 PM EST
6.18 +0.26 +4.39%
After hours · Nov 11, 4:00 PM ET
5.51 Day range 5.94
4.75 52-week range 12.18
- YTD
- -32.88%
- 1 year
- -33.41%
News
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva SE (NASDAQ:VALN) reported positive five-year antibody persistence results for its single-dose chikungunya vaccine, IXCHIQ, confirming that the shot delivers lasting immune protection across…
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva reports 94% of adults sustained antibody protection five years after receiving its single-dose chikungunya shot IXCHIQ.
benzinga.com Valneva Says Single-Dose Chikungunya Vaccine IXCHIQ Showed Antibody Persistence Consistent With Prior Results, In Line With Company Expectations, With 94% Seroresponse At Year 5 Across Age Groups 94% of participants maintained seroresponse five years after a single vaccinationComparable antibody persistence observed in older (65+) and younger adultsData further reinforce IXCHIQ®'s…
globenewswire.com Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ® Lyon (France), November 10, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive five-year antibody persistence data for its single dose…
benzinga.com Valneva Evaluates Next Steps for Bacterial Infection Vaccine Following Successful Phase 2 Studies Valneva SE (NASDAQ:VALN) announced positive data from two Phase 2 clinical trials evaluating Shigella4V2 (S4V2), the world's most clinically advanced tetravalent bioconjugate candidate targeting…
globenewswire.com Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2 Data from infant immunogenicity and safety trial, and controlled human infection model (CHIM) trial, demonstrate favorable safety profile with encouraging immunogenicity and efficacy signals
globenewswire.com Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026 Lyon (France), November 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its nine-month 2026 financial results on Tuesday,…
globenewswire.com Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with…
benzinga.com Full Transcript: Valneva Q2 2026 Earnings Call Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
benzinga.com UK Revokes Approval for Valneva's Chikungunya Shot UK MHRA revokes Valneva’s IXCHIQ chikungunya vaccine authorization over traveler benefit-risk review. Minimal financial impact expected.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98%…
globenewswire.com Valneva Provides Update on IXCHIQ® in the United Kingdom Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for…
defenseworld.net Analyzing Valneva (NASDAQ:VALN) and Septerna (NASDAQ:SEPN) Valneva (NASDAQ: VALN - Get Free Report) and Septerna (NASDAQ: SEPN - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based…
defenseworld.net Contrasting Absci (NASDAQ:ABSI) & Valneva (NASDAQ:VALN) Valneva (NASDAQ: VALN - Get Free Report) and Absci (NASDAQ: ABSI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based…
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
benzinga.com Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session Stock futures mixed, Nasdaq 100 down 100 points. Applied Optoelectronics falls after announcing $600M offering. Other pre-market losers include RFAI, ZSTK, ZKH, JMIA, VALN, MFI, COHR, SNDK, AXTI,…
seekingalpha.com Valneva: The Lyme Royalty Transition Changes The Earnings Model Valneva (VALN) is transitioning from a low-margin vaccine manufacturer to a high-margin royalty and milestone model, anchored by its Lyme disease partnership with Pfizer. Recent financials were…
benzinga.com European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application Valneva SE (NASDAQ:VALN) stock is surging on Friday after the company and its partner Pfizer Inc. (NYSE:PFE) announced that the European Medicines Agency (EMA) has validated the Marketing…
benzinga.com European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.
benzinga.com Dow Falls Over 100 Points; US Consumer Sentiment Declines In August Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail sales down 0.6%, consumer sentiment declines.
benzinga.com Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
benzinga.com Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
businesswire.com Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency NEW YORK & LYON, France--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the…
globenewswire.com Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency NEW YORK & LYON, France, August, 14, 2026 Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the…
seekingalpha.com Valneva SE (VALN) Q2 2026 Earnings Call Transcript Valneva SE (VALN) Q2 2026 Earnings Call Transcript
marketbeat.com Valneva Q2 Earnings Call Highlights Valneva NASDAQ: VALN reported lower first-half revenue and wider losses for 2026, while maintaining its full-year sales outlook and emphasizing its cash position, restructuring measures and…
benzinga.com Conference Call:
Valneva Affirms FY2026 Sales Guidance of $169.795M-$187.360M vs $171.630M Est Valneva (NASDAQ:VALN) affirms FY2026 sales outlook from $169.795 million-$187.360 million to $169.795 million-$187.360 million vs $171.630 million estimate.
benzinga.com Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY Total product sales of €64.0 millionIn-line with expectations; full-year guidance of €135 -150 million reaffirmedSolid cash position of €121.5 million as of end June 2026Reflects disciplined cash…
globenewswire.com Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates Lyon (France), August 13, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its condensed consolidated financial results for the first half of the…
globenewswire.com Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités Ventes totales de produits de 64,0 millions d'euros o En ligne avec les attentes; confirmation de la prévision annuelle de ventes comprises entre 135 et 150 millions d'euros. Solide position de…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global…
globenewswire.com Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026 Lyon (France), July 22, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first half 2026 financial results on Thursday,…
seekingalpha.com Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript
globenewswire.com Valneva Announces Successful Outcome of its Annual General Meeting Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that…- benzinga.com Transcript: Valneva Q1 2026 Earnings Conference Call
- benzinga.com Valneva Lowers FY2026 Sales Guidance from $180.443M-$197.906M to $169.795M-$187.360M vs $192.800M Est Valneva (NASDAQ:VALN) lowers FY2026 sales outlook from $180.443 million-$197.906 million to $169.795 million-$187.360 million vs $192.800 million estimate.
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com Valneva Q1 EPS $(0.42) Misses $(0.21) Estimate, Sales $36.189M Miss $46.270M Estimate Valneva (NASDAQ:VALN) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.21) by 100 percent. This is a 223.08 percent decrease over losses of $(0.13)…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.
benzinga.com Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Dow futures up 250 points. Sonoco Products Co (SON) shares down 5.7% in pre-market after reporting lower-than-expected earnings and sales.
benzinga.com Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Crude Oil Falls Sharply; Dell Shares Spike Higher Dow up 2.45%, Nasdaq up 2.46%, S&P 500 up 2.19%. Consumer discretionary shares up 3.6%, energy stocks up 0.3%. Dell announces enhancements, BofA raises price target. Apogee up 17%, Tower Semi up 9%,…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive Valneva stock drops after Phase 3 Lyme vaccine misses primary endpoint; secondary data shows efficacy as Pfizer backs regulatory submissions.
benzinga.com Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February Dow Jones rises over 800 points on Monday as U.S. stocks trade higher. NASDAQ and S&P 500 also see gains. Consumer discretionary shares climb, construction spending falls.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down.